H.R. 6033 — Introduced in House

I 114th CONGRESS 2d Session H. R. 6033 IN THE HOUSE OF REPRESENTATIVES September 14, 2016Mr. Peters (for himself, Mr. Rothfus, and Mr. Brendan F. Boyle of Pennsylvania) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To expand the tropical disease product priority review voucher program to encourage treatments for the Middle East respiratory syndrome. 1. Short title This Act may be cited as the Adding Middle East Respiratory Syndrome to the FDA Priority Review Voucher Program Act. 2. Expanding tropical disease product priority review voucher program to encourage treatments for Middle East respiratory syndrome Section 524(a)(3) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360n(a)(3)) is amended— (1) by redesignating subparagraph (S) as subparagraph (T); and (2) by inserting after subparagraph (R) the following: (S) Middle East respiratory syndrome. .